{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:44:26Z","timestamp":1787755466971,"version":"build-2784847793"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Although clinical guidelines endorse enoxaparin for the prevention of venous thromboembolism in patients with orthopaedic trauma, recent evidence from a large clinical trial has demonstrated that aspirin provides comparable protection against death and pulmonary embolism. This study evaluated the cost-effectiveness of thromboprophylaxis with enoxaparin compared with that with aspirin in patients with orthopaedic trauma from the perspective of the U.S. health-care system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The study modeled a hypothetical cohort of adult patients with an operatively treated extremity, pelvic, or acetabular fracture based on data from a recent clinical trial and national databases. We used a decision analysis model to compare 30 mg of enoxaparin with 81 mg of aspirin, administered twice daily in-hospital and prescribed for 21 days after discharge. Health-care costs and quality-adjusted life-years (QALYs) within 1 year after the injury derived from published research and publicly available cost data were based on potential disease states, including death or a combination of pulmonary embolism, proximal deep vein thrombosis, distal deep vein thrombosis, or a bleeding complication. We assessed cost-effectiveness compared with a willingness-to-pay threshold of $150,000 per QALY.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our model estimated that the 1-year health-care costs among patients prescribed enoxaparin were $35,301, producing 0.6705 QALYs. Aspirin was associated with $35,067 in 1-year health-care costs and 0.6701 QALYs. The overall health-care costs were $234 higher with enoxaparin but yielded only a 0.0004 improvement in QALYs, for an incremental cost-effectiveness ratio for enoxaparin of $635,340 per QALY, indicating that enoxaparin is not cost-effective compared with aspirin. In a sensitivity analysis, the probability of enoxaparin thromboprophylaxis being cost-effective compared with aspirin was 9.8% in 10,000 iterations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The findings suggest that enoxaparin is not cost-effective relative to aspirin for thromboprophylaxis in patients with orthopaedic trauma. The results support consideration of aspirin as a preferred agent in future guidelines, especially given the consistent patient preference for its oral administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Economic and Decision Analysis\n                      <jats:underline>Level I<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.25.00681","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T19:00:11Z","timestamp":1769454011000},"page":"e9","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Cost-Effectiveness of Enoxaparin Compared with Aspirin for Thromboprophylaxis in Patients with Orthopaedic Trauma"],"prefix":"10.2106","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9317-5306","authenticated-orcid":false,"given":"Joseph F.","family":"Levy","sequence":"first","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"O\u2019Toole","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3683-3963","authenticated-orcid":false,"given":"Deborah M.","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Surgery, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-771X","authenticated-orcid":false,"given":"Elliott R.","family":"Haut","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Surgery, Johns Hopkins Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5305-1774","authenticated-orcid":false,"given":"Katherine P.","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan C.","family":"Castillo","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan N.","family":"O\u2019Hara","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Major Extremity Trauma Research Consortium (METRC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"3","key":"bib1-20260506","first-page":"CD008303","article-title":"Thromboprophylaxis for trauma patients","volume":"2013","author":"Barrera","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"bib2-20260506","doi-asserted-by":"crossref","DOI":"10.1097\/01.sla.0000137138.40116.6c","article-title":"Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank","volume":"240","author":"Knudson","year":"2004","journal-title":"Ann Surg."},{"issue":"4","key":"bib3-20260506","article-title":"Predictors of posttraumatic deep vein thrombosis (DVT): hospital practice versus patient factors-an analysis of the National Trauma Data Bank (NTDB)","volume":"66","author":"Haut","year":"2009","journal-title":"J Trauma."},{"issue":"3","key":"bib4-20260506","doi-asserted-by":"crossref","DOI":"10.1177\/1062860613494751","article-title":"Using AHRQ patient safety indicators to detect postdischarge adverse events in the Veterans Health Administration","volume":"29","author":"Mull","year":"2014","journal-title":"Am J Med Qual."},{"issue":"6","key":"bib5-20260506","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2010.07.007","article-title":"Validity of selected patient safety indicators: opportunities and concerns","volume":"212","author":"Kaafarani","year":"2011","journal-title":"J Am Coll Surg."},{"issue":"2","key":"bib6-20260506","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in Orthopedic Surgery Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest."},{"issue":"1","key":"bib7-20260506","first-page":"e35","article-title":"Venous thromboembolism prophylaxis in orthopaedic trauma patients: a survey of OTA member practice patterns and OTA expert panel recommendations","volume":"30","author":"Sagi","year":"2016","journal-title":"J Orthop Trauma."},{"issue":"1","key":"bib8-20260506","doi-asserted-by":"crossref","DOI":"10.1097\/00005373-200207000-00032","article-title":"Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group","volume":"53","author":"Rogers","year":"2002","journal-title":"J Trauma."},{"key":"bib9-20260506","doi-asserted-by":"crossref","DOI":"10.1016\/j.jss.2019.12.023","article-title":"The national burden of orthopedic injury: cross-sectional estimates for trauma system planning and optimization","volume":"249","author":"Jarman","year":"2020","journal-title":"J Surg Res."},{"issue":"2","key":"bib10-20260506","article-title":"American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest","volume":"141","author":"Guyatt","year":"2012"},{"issue":"18","key":"bib11-20260506","doi-asserted-by":"crossref","DOI":"10.5435\/JAAOS-D-19-00409","article-title":"Venous thromboembolism prophylaxis after pelvic and acetabular fractures: a survey of orthopaedic surgeons\u2019 current practices","volume":"28","author":"Lim","year":"2020","journal-title":"J Am Acad Orthop Surg."},{"issue":"1","key":"bib12-20260506","doi-asserted-by":"crossref","first-page":"e001070","DOI":"10.1136\/tsaco-2022-001070","article-title":"Survey of venous thromboembolism prophylaxis in trauma patients: current prescribing practices and concordance with clinical practice guidelines","volume":"8","author":"Alexander","year":"2023","journal-title":"Trauma Surg Acute Care Open."},{"issue":"1","key":"bib13-20260506","doi-asserted-by":"crossref","first-page":"e001511","DOI":"10.1136\/tsaco-2024-001511","article-title":"Venous thromboembolism prophylaxis prescribing patterns for patients with orthopedic trauma: a clinical vignette survey","volume":"9","author":"O\u2019Hara","year":"2024","journal-title":"Trauma Surg Acute Care Open."},{"issue":"2","key":"bib14-20260506","doi-asserted-by":"crossref","DOI":"10.1002\/jhm.2282","article-title":"Patient preferences regarding pharmacologic venous thromboembolism prophylaxis","volume":"10","author":"Wong","year":"2015","journal-title":"J Hosp Med."},{"key":"bib15-20260506","doi-asserted-by":"crossref","first-page":"105446","DOI":"10.1016\/j.yrtph.2023.105446","article-title":"Scientific considerations in the regulatory approval of generic (or biosimilar) version of enoxaparin sodium - a lifesaving carbohydrate polymer","volume":"143","author":"Iqbal","year":"2023","journal-title":"Regul Toxicol Pharmacol."},{"issue":"8S1","key":"bib16-20260506","article-title":"Trends in deep vein thrombosis prophylaxis after total knee arthroplasty: 2016 to 2021","volume":"39","author":"Dubin","year":"2024","journal-title":"J Arthroplasty."},{"issue":"3","key":"bib17-20260506","doi-asserted-by":"crossref","first-page":"e041845","DOI":"10.1136\/bmjopen-2020-041845","article-title":"METRC. PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients","volume":"11","author":"O\u2019Toole","year":"2021","journal-title":"BMJ Open."},{"issue":"3","key":"bib18-20260506","article-title":"Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture","volume":"388","author":"O\u2019Toole","year":"2023","journal-title":"N Engl J Med."},{"issue":"6","key":"bib19-20260506","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2023.07.041","article-title":"Below the knee, let it be: management of calf DVT in hospitalized trauma patients","volume":"226","author":"Kay","year":"2023","journal-title":"Am J Surg."},{"issue":"4","key":"bib20-20260506","article-title":"Risk-stratified thromboprophylaxis effects of aspirin versus low-molecular-weight heparin in orthopedic trauma patients: a secondary analysis of the PREVENT CLOT trial","volume":"96","author":"O\u2019Hara","year":"2024","journal-title":"J Trauma Acute Care Surg."},{"issue":"7","key":"bib21-20260506","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.23.00824","article-title":"METRC. Effect of aspirin versus low-molecular-weight heparin thromboprophylaxis on medication satisfaction and out-of-pocket costs: a secondary analysis of a randomized clinical trial","volume":"106","author":"O\u2019Hara","year":"2024","journal-title":"J Bone Joint Surg Am."},{"issue":"8","key":"bib22-20260506","doi-asserted-by":"crossref","first-page":"e016676","DOI":"10.1136\/bmjopen-2017-016676","article-title":"Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment","volume":"7","author":"Haac","year":"2017","journal-title":"BMJ Open."},{"issue":"4","key":"bib23-20260506","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0000000000001771","article-title":"Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: results from a randomized controlled trial of aspirin versus low molecular weight heparin","volume":"84","author":"Haac","year":"2018","journal-title":"J Trauma Acute Care Surg."},{"key":"bib24-20260506","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2017.10.012","article-title":"Exploring the impact of route of administration on medication acceptance in hospitalized patients: implications for venous thromboembolism prevention","volume":"160","author":"Popoola","year":"2017","journal-title":"Thromb Res."},{"issue":"6","key":"bib25-20260506","doi-asserted-by":"crossref","DOI":"10.2146\/ajhp161057","article-title":"Nonadministration of medication doses for venous thromboembolism prophylaxis in a cohort of hospitalized patients","volume":"75","author":"Popoola","year":"2018","journal-title":"Am J Health Syst Pharm."},{"issue":"3","key":"bib26-20260506","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe2214045","article-title":"Thromboprophylaxis after extremity fracture - time for aspirin?","volume":"388","author":"Costa","year":"2023","journal-title":"N Engl J Med."},{"issue":"15","key":"bib27-20260506","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad098","article-title":"Aspirin for venous thromboprophylaxis after fracture: ready for prime time?","volume":"44","author":"Vergallo","year":"2023","journal-title":"Eur Heart J."},{"key":"bib32-20260506","year":"2024","journal-title":"NADAC (National Average Drug Acquisition Cost)"},{"issue":"6","key":"bib34-20260506","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2023.02.018","article-title":"Decision-analysis modeling of effectiveness and cost-effectiveness of pharmacologic thromboprophylaxis for surgical inpatients using variable risk assessment models or other strategies","volume":"21","author":"Davis","year":"2023","journal-title":"J Thromb Haemost."},{"issue":"1","key":"bib35-20260506","doi-asserted-by":"crossref","first-page":"e000408","DOI":"10.1136\/bmjmed-2022-000408","article-title":"Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study","volume":"3","author":"Davis","year":"2024","journal-title":"BMJ Med."},{"issue":"8","key":"bib36-20260506","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znad144","article-title":"Impact of surgical-site infection on health utility values: a meta-analysis","volume":"110","author":"McFarland","year":"2023","journal-title":"Br J Surg."},{"key":"bib37-20260506","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3389\/fphar.2018.01370","article-title":"Cost-utility analysis of venous thromboembolism prophylaxis strategies for people undergoing elective total hip and total knee replacement surgeries in the English National Health Service","volume":"9","author":"Dawoud","year":"2018","journal-title":"Front Pharmacol."},{"issue":"1","key":"bib38-20260506","doi-asserted-by":"crossref","DOI":"10.3109\/17453674.2010.548026","article-title":"Health-related quality of life (EQ-5D) before and after orthopedic surgery","volume":"82","author":"Jansson","year":"2011","journal-title":"Acta Orthop."},{"issue":"1","key":"bib39-20260506","doi-asserted-by":"crossref","DOI":"10.1302\/0301-620X.100B1.BJJ-2017-0955.R1","article-title":"Wound irrigation does not affect health-related quality of life after open fractures: results of a randomized controlled trial","volume":"100-B","author":"Sprague","year":"2018","journal-title":"Bone Joint J."},{"issue":"1","key":"bib40-20260506","doi-asserted-by":"crossref","first-page":"e038707","DOI":"10.1136\/bmjopen-2020-038707","article-title":"Prognostic factors for recovery of health status after injury: a prospective multicentre cohort study","volume":"11","author":"de Munter","year":"2021","journal-title":"BMJ Open."},{"issue":"10","key":"bib41-20260506","doi-asserted-by":"crossref","DOI":"10.2165\/11313800-000000000-00000","article-title":"A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the Irish healthcare setting","volume":"27","author":"McCullagh","year":"2009","journal-title":"Pharmacoeconomics."},{"issue":"9","key":"bib42-20260506","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med."},{"issue":"15","key":"bib43-20260506","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2023.1792","article-title":"Cost-effectiveness thresholds used by study authors, 1990-2021","volume":"329","author":"Neumann","year":"2023","journal-title":"JAMA."},{"issue":"9","key":"bib45-20260506","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-7568(21)00172-0","article-title":"Global, regional, and national burden of bone fractures in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"2","author":"Wu","year":"2021","journal-title":"Lancet Healthy Longev."},{"issue":"6","key":"bib46-20260506","doi-asserted-by":"crossref","DOI":"10.1111\/jth.13677","article-title":"Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis","volume":"15","author":"Franco","year":"2017","journal-title":"J Thromb Haemost."},{"key":"bib47-20260506","article-title":"METRC and Major Extremity Trauma Research Consortium (METRC) Corporate Author. Cost savings of switching to aspirin for thromboprophylaxis in orthopaedic trauma patients: a budget impact analysis","author":"Levy","year":"2025","journal-title":"J Am Acad Orthop Surg."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.25.00681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:43:21Z","timestamp":1787751801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.25.00681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.25.00681","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]}}}